The Full Wiki

Tenofovir: Quiz

  
  

Question 1: A 2006 trial by Family Health International gave either Viread or a placebo to 936 high-risk women in ________, Ghana and Nigeria.
KenyaCameroonSudanMadagascar

Question 2: Tenofovir was approved by the U.S. Food and Drug Administration (FDA) on October 26, 2001 for the treatment of HIV, and on August 11, 2008 for the treatment of chronic ________[2][3].
Herpes simplex virusHepatitis BAIDSHerpes simplex

Question 3: Tenofovir can cause ________, Fanconi syndrome, proteinuria, tubular necrosis.
Chronic kidney diseaseKidney stoneRenal tubular acidosisAcute kidney injury
















Got something to say? Make a comment.
Your name
Your email address
Message